Trial · NCT01325337
Results by group135
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 135
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline in Target Area Hair Count (TAHC) | Bimatoprost Formulation A | Baseline | 135.0 | Standard Deviation 58.80 | terminal hairs/cm^2 |
| Change From Baseline in Target Area Hair Count (TAHC) | Bimatoprost Formulation B | Baseline | 145.7 | Standard Deviation 57.25 | terminal hairs/cm^2 |
| Change From Baseline in Target Area Hair Count (TAHC) | Bimatoprost Formulation C | Baseline | 151.5 | Standard Deviation 60.40 | terminal hairs/cm^2 |
| Change From Baseline in Target Area Hair Count (TAHC) | Vehicle to Bimatoprost | Baseline | 143.7 | Standard Deviation 55.42 | terminal hairs/cm^2 |
| Change From Baseline in Target Area Hair Count (TAHC) | Minoxidil 5% Solution | Baseline | 132.7 | Standard Deviation 53.14 | terminal hairs/cm^2 |
| Change From Baseline in Target Area Hair Count (TAHC) | Bimatoprost Formulation A | Change from Baseline at Month 6 | 13.1 | Standard Deviation 21.69 | terminal hairs/cm^2 |
| Change From Baseline in Target Area Hair Count (TAHC) | Bimatoprost Formulation B | Change from Baseline at Month 6 | 6.1 | Standard Deviation 19.80 | terminal hairs/cm^2 |
| Change From Baseline in Target Area Hair Count (TAHC) | Bimatoprost Formulation C | Change from Baseline at Month 6 | 6.3 | Standard Deviation 22.05 | terminal hairs/cm^2 |
| Change From Baseline in Target Area Hair Count (TAHC) | Vehicle to Bimatoprost | Change from Baseline at Month 6 | 4.1 | Standard Deviation 15.59 | terminal hairs/cm^2 |
| Change From Baseline in Target Area Hair Count (TAHC) | Minoxidil 5% Solution | Change from Baseline at Month 6 | 21.9 | Standard Deviation 19.30 | terminal hairs/cm^2 |
| Percentage of Participants in Each Response Category of the Subject Self Assessment in Alopecia (SSA) Score | Bimatoprost Formulation A | Greatly Increased | 0.0 | Percentage of participants | |
| Percentage of Participants in Each Response Category of the Subject Self Assessment in Alopecia (SSA) Score | Bimatoprost Formulation B | Greatly Increased | 1.7 | Percentage of participants | |
| Percentage of Participants in Each Response Category of the Subject Self Assessment in Alopecia (SSA) Score | Bimatoprost Formulation C | Greatly Increased | 0.0 | Percentage of participants | |
| Percentage of Participants in Each Response Category of the Subject Self Assessment in Alopecia (SSA) Score | Vehicle to Bimatoprost | Greatly Increased | 1.7 | Percentage of participants | |
| Percentage of Participants in Each Response Category of the Subject Self Assessment in Alopecia (SSA) Score | Minoxidil 5% Solution | Greatly Increased | 5.2 | Percentage of participants | |
| Percentage of Participants in Each Response Category of the Subject Self Assessment in Alopecia (SSA) Score | Bimatoprost Formulation A | Moderately Increased | 8.6 | Percentage of participants | |
| Percentage of Participants in Each Response Category of the Subject Self Assessment in Alopecia (SSA) Score | Bimatoprost Formulation B | Moderately Increased | 11.9 | Percentage of participants | |
| Percentage of Participants in Each Response Category of the Subject Self Assessment in Alopecia (SSA) Score | Bimatoprost Formulation C | Moderately Increased | 11.7 | Percentage of participants | |
| Percentage of Participants in Each Response Category of the Subject Self Assessment in Alopecia (SSA) Score | Vehicle to Bimatoprost | Moderately Increased | 6.9 | Percentage of participants | |
| Percentage of Participants in Each Response Category of the Subject Self Assessment in Alopecia (SSA) Score | Minoxidil 5% Solution | Moderately Increased | 27.6 | Percentage of participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01325337/results